Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Mar 04, 2021 10:59pm
94 Views
Post# 32725200

RE:RE:$4.91

RE:RE:$4.91
Benedict16th wrote: More deep losses to come. After GBT investment debacle and more than 70% market devalued  down the market/investors are now worried about a second next bad investment debacle to come for the rest of remaining  300 Million more or less. This company has been badly managed for a long...long time and it may continue for a long ...long time if MNGT remain thought .....I doubt it. Seven Years facts, charts and from $10.70 to $4.91. Serious losses have ben accumulated with wounded Knight. So when you read that some pumpers are accumulating they actual mean that they are accumulating seven Years of more losses



Expect a writedown of the GBT boondoggle, this is most likely why the market has dropped this turd down another 20%. By the time this disaster of a purchase closed it was already worth 25% less. How much is it worth today? And yes, the only thing from keeping this turd to going sub $1.00 is the cash, which management will be apprehensive to spend other than investing and lending a few million to companies trading 10-20 cents. So you can look forward to more of...nothing. One of the worst performing companies on the entire Toronto exchange the past few years an incredible difficult accomplishment with markets at record highs. Hats off.. 
<< Previous
Bullboard Posts
Next >>